preview

Voriconazole Comparison

Satisfactory Essays
This study is the first to compare between posaconazole and voriconazole from an economic perspective in their use as prophylactic gents against fungal infections in patients with AML. Such study is important in decision making considering economics aspects when choosing between posaconazole and voriconazole especially in RMH in Australia. The main finding of this study is that posaconazole is more cost saving than voriconazole. It was reported by the study that the main influence on voriconazole cost is the discontinuation of the drug due to intolerance of oral dosage form (other alternatives were given). One study was done in Singapore to compare cost-effectiveness between different triazoles in IFI prophylaxis using network meta-analysis
Get Access